IMMUNOMEDICS INC's ticker is and the CUSIP is 452907AK4. A total of 5 filers reported holding IMMUNOMEDICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $19,166,000 | +56.8% | 4,614,000 | 0.0% | 0.22% | +43.9% |
| Q3 2019 | $12,226,000 | -4.0% | 4,614,000 | 0.0% | 0.16% | -6.6% |
| Q2 2019 | $12,729,000 | -27.6% | 4,614,000 | 0.0% | 0.17% | -30.8% |
| Q1 2019 | $17,575,000 | +32.9% | 4,614,000 | +0.2% | 0.24% | +50.9% |
| Q4 2018 | $13,228,000 | -16.0% | 4,605,000 | +21.0% | 0.16% | -13.1% |
| Q3 2018 | $15,748,000 | -10.9% | 3,805,000 | 0.0% | 0.18% | -20.1% |
| Q2 2018 | $17,680,000 | +52.2% | 3,805,000 | -3.7% | 0.23% | +52.7% |
| Q1 2018 | $11,618,000 | -4.1% | 3,950,000 | +5.3% | 0.15% | +22.0% |
| Q4 2017 | $12,121,000 | -33.8% | 3,750,000 | -62.5% | 0.12% | -47.2% |
| Q2 2017 | $18,308,000 | +30.5% | 10,010,000 | 0.0% | 0.23% | +6.9% |
| Q1 2017 | $14,034,000 | +40.3% | 10,010,000 | 0.0% | 0.22% | +69.0% |
| Q4 2016 | $10,003,000 | +11.2% | 10,010,000 | 0.0% | 0.13% | -3.7% |
| Q3 2016 | $8,996,000 | +29.2% | 10,010,000 | +0.1% | 0.13% | +26.4% |
| Q2 2016 | $6,962,000 | -2.8% | 10,000,000 | 0.0% | 0.11% | -48.0% |
| Q1 2016 | $7,161,000 | – | 10,000,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Graham Capital Management, L.P. | 17,594,000 | $51,944,000 | 1.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 3,950,000 | $11,618,000 | 0.15% |
| Jefferies Group LLC | 3,889,000 | $11,591,000 | 0.06% |
| Calamos Advisors LLC | 2,500,000 | $7,324,000 | 0.05% |
| AMERIPRISE FINANCIAL INC | 1,000,000 | $2,950,000 | 0.00% |